Recent Patent Cases and Generic Delays: 2023-2025 Examples
Despite FDA approval, many generic drugs remain unavailable due to patent litigation delays between 2023 and 2025. Learn how patent thicketing, the 30-month stay, and high legal costs block affordable access to essential medications.
Read More
Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with faster market access. It saved billions and now faces new challenges from patent abuse.
Read More
